首页> 外文期刊>FEBS Open Bio >miRNA‐765 mediates multidrug resistance via targeting BATF2 in gastric cancer cells
【24h】

miRNA‐765 mediates multidrug resistance via targeting BATF2 in gastric cancer cells

机译:MiRNA-765通过靶向BATF2在胃癌细胞中介导多药耐药性

获取原文
           

摘要

Elucidation of the mechanisms underlying multidrug resistance (MDR) is required to ensure the efficacy of chemotherapy against gastric cancer (GC). To investigate this issue, here we identified that microRNA‐765 (miRNA‐765) is up‐regulated both in MDR GC cell lines and in specimens from patients who are not responding to chemotherapy. In addition, down‐regulation of miRNA‐765 increased the sensitivity of GC cells to anticancer drugs, whereas its overexpression had the opposite effect. Moreover, miRNA‐765 suppressed drug‐induced apoptosis and positively regulated the expression of MDR‐related genes. Finally, we showed that the basic leucine zipper ATF‐like transcription factor 2, a tumor suppressor gene, is the functional target of miRNA‐765. In summary, these results suggest that miRNA‐765 may promote MDR via basic leucine zipper ATF‐like transcription factor 2 in GC cells.
机译:需要阐明多药抗性(MDR)的机制,以确保化疗对胃癌(GC)的功效。为了调查这个问题,在这里,我们将MicroRNA-765(miRNA-765)识别在MDR GC细胞系中,以及来自未响应化疗的患者的标本。此外,MiRNA-765的下调增加了GC细胞对抗癌药物的敏感性,而其过度表达具有相反的效果。此外,MiRNA-765抑制了药物诱导的细胞凋亡,并积极调节MDR相关基因的表达。最后,我们表明,基本亮氨酸拉链atf样转录因子2,肿瘤抑制基因是miRNA-765的功能靶标。总之,这些结果表明miRNA-765可以通过GC细胞中通过碱性亮氨酸拉链ATF样转录因子2促进MDR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号